SenseToKnow Autism Screening Device Validation Study
SenseToKnow STAR Study: A Study of Technologies for Assessing Children's Development
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Geraldine Dawson, PhD
- Phone Number: 9196680070
- Email: geraldine.dawson@duke.edu
Study Contact Backup
- Name: Charlotte Stoute, BA
- Phone Number: 919-681-9730
- Email: charlotte.stoute@duke.edu
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Recruiting
- Duke University
-
Contact:
- Geraldine Dawson, PhD
- Phone Number: 919-668-0070
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Duke Health pediatric patient at enrollment
- 16-<37 months of age at enrollment
- Parent/legal guardian speaks English or Spanish
- Parent/legal guardian understands and voluntarily provides informed consent
Exclusion Criteria:
- Severe motor impairment that precludes study measure completion
- Known genetic disorders
- Severe hearing or visual impairment as determined on physical examination according to parent report
- Acute illnesses likely to prevent successful or valid data collection
- Uncontrolled epilepsy or seizure disorder
- History or presence of a clinically significant medical disease, or a mental state that could confound the study or be detrimental to the subject as determined by the investigator
- Acute exacerbations of chronic illnesses likely to prevent successful or valid data collection
- Receiving therapies that affect vision
- Parent/legal guardian and/or investigator believes that the child will be unable/unwilling to sit in the parent's lap to watch the app videos
- Parent/legal guardian indicates that they or their child is unwilling or unable to complete the app administration, surveys, or diagnostic assessment
- Participants who are otherwise judged as unable to comply with the protocol by the investigator
- Any other factor that the investigator feels would make the study measures invalid
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Pediatric patients, 16-36 months of age, recruited through pediatric medical clinics
Consecutive pediatric participants will be recruited and enrolled via >= 6 participating sites comprised of pediatric medical clinics (e.g., primary care and family medicine clinics) that are part of the broader Duke University Health System (DUHS) located in North Carolina.
Enrollment will proceed until the targets of N = 150 participants diagnosed with autism spectrum disorder and N = 200 without autism are reached.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sensitivity of the SenseToKnow screening device based on a machine learning algorithm that combines SenseToKnow digital data with data from the SenseToKnow Caregiver survey for autism detection
Time Frame: Will be calculated based on data from Baseline/Timepoint 1
|
Sensitivity = #participants positive for autism on both (1) the SenseToKnow screening device based on a machine learning algorithm that combines SenseToKnow digital data with the SenseToKnow Caregiver Survey data and (2) expert clinical diagnosis / #participants positive for autism on both SenseToKnow and expert clinical diagnosis
|
Will be calculated based on data from Baseline/Timepoint 1
|
|
Specificity of the SenseToKnow screening device based on machine earning algorithm that combines SenseToKnow digital data with data from the SenseToKnow Caregiver survey for autism detection
Time Frame: Will be calculated based on data from Baseline/Timepoint 1
|
Specificity = #participants negative for autism on both (1) the SenseToKnow screening device based on a machine learning algorithm that combines SenseToKnow digital data with the SenseToKnow Caregiver Survey data, and (2) expert clinical diagnosis / #participants negative for autism on autism by expert clinical diagnosis
|
Will be calculated based on data from Baseline/Timepoint 1
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Positive Predictive Value of SenseToKnow screening device (based on a machine learning algorithm using the SenseToKnow digital data, combined with the SenseToKnow Caregiver Survey data) for autism detection in comparison to expert clinical diagnosis
Time Frame: Will be calculated based on data from Baseline/Timepoint 1
|
The likelihood that a participant with a positive test result (based on a machine learning algorithm using the SenseToKnow digital data, combined with the SenseToKnow Caregiver Survey data) has a diagnosis of autism (based on expert clinical diagnosis).
Positive Predictive Value will be calculated with and without adjustment for population prevalence.
|
Will be calculated based on data from Baseline/Timepoint 1
|
|
Negative Predictive Value of SenseToKnow screening device (based on a machine learning algorithm using the SenseToKnow digital data, combined with the SenseToKnow Caregiver Survey data) for autism detection in comparison to expert clinical diagnosis
Time Frame: Will be calculated based on data from Baseline/Timepoint 1
|
The likelihood that a participant with a negative test result (based on a machine learning algorithm using the SenseToKnow digital data, combined with the SenseToKnow Caregiver Survey data) does not have a diagnosis of autism (based on expert clinical diagnosis).
Negative Predictive Value will be calculated with and without adjustment for population prevalence.
|
Will be calculated based on data from Baseline/Timepoint 1
|
|
Receiver Operating Characteristic Curve and Area Under the Curve with respect to the accuracy of the SenseToKnow screening device (using the SenseToKnow digital data and SenseToKnow Caregiver survey data) for autism versus non-autism classification
Time Frame: Will be calculated based on data from Baseline/Timepoint 1
|
Receiver Operating Characteristic Curve (ROC) is a graphical plot that illustrates the diagnostic ability of a binary classifier system as its discrimination threshold is varied.
Area Under the Curve (AUC) measures the area underneath the entire ROC curve.
Accuracy of test is based on a machine learning algorithm using the SenseToKnow digital data, combined with the SenseToKnow Caregiver Survey data, in comparison to expert clinical diagnosis.
|
Will be calculated based on data from Baseline/Timepoint 1
|
|
Sensitivity of SenseToKnow screening device based on a machine learning algorithm using only the SenseToKnow digital data for autism detection
Time Frame: Will be calculated based on data from Baseline/Timepoint 1
|
Sensitivity = #participants positive for autism on both (1) the SenseToKnow screening device based on a machine learning algorithm using only the SenseToKnow digital data and (2) expert clinical diagnosis / # participants positive for autism on expert clinical diagnosis
|
Will be calculated based on data from Baseline/Timepoint 1
|
|
Specificity of SenseToKnow screening device based on a machine learning algorithm using only the SenseToKnow digital data for autism detection
Time Frame: Will be calculated based on data from Baseline/Timepoint 1
|
Specificity = #participants negative for autism on both (1) the SenseToKnow screening device based on a machine learning algorithm using only the SenseToKnow digital data and (2) expert clinical diagnosis / #participants negative for autism on expert clinical diagnosis.
|
Will be calculated based on data from Baseline/Timepoint 1
|
|
Positive Predictive Value of SenseToKnow screening device based on a machine learning algorithm using only the SenseToKnow digital data for autism detection in comparison to expert clinical diagnosis
Time Frame: Will be calculated based on data from Baseline/Timepoint 1
|
The likelihood that a participant with a positive test result has a diagnosis of autism (based on expert clinical diagnosis).
Positive Predictive Value will be calculated with and without adjustment for population prevalence.
|
Will be calculated based on data from Baseline/Timepoint 1
|
|
Negative Predictive Value of SenseToKnow screening device based on a machine learning algorithm using only the SenseToKnow digital data for autism detection in comparison to expert clinical diagnosis
Time Frame: Will be calculated based on data from Baseline/Timepoint 1
|
The likelihood that a participant with a negative test result does not have a diagnosis of autism (based on expert clinical diagnosis).
Negative Predictive Value will be calculated with and without adjustment for population prevalence.
|
Will be calculated based on data from Baseline/Timepoint 1
|
|
Receiver Operating Characteristic Curve and Area Under the Curve with respect to the accuracy of the SenseToKnow device using only the SenseToKnow digital data for autism versus non-autism classification
Time Frame: Will be calculated based on data from Baseline/Timepoint 1
|
Receiver Operating Characteristic Curve (ROC) is a graphical plot that illustrates the diagnostic ability of a binary classifier system as its discrimination threshold is varied.
Area Under the Curve (AUC) measures the area underneath the entire ROC curve.
Accuracy of test is based on a machine learning algorithm using only the SenseToKnow digital data, in comparison to expert clinical diagnosis.
|
Will be calculated based on data from Baseline/Timepoint 1
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Geraldine Dawson, PhD, Duke University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Pro00111371
- 2P50HD093074 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.